PHPeter Hornbeck

Peter Hornbeck

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Peter Hornbeck has a total of 295 co-authors. Here are the top co-authors by number of shared publications:

  • Bin Zhang

    Department of Bioinformatics and Computational Biology, Cell Signaling Technology Inc, Danvers, MA, USA

    7 shared publications
  • Beth Murray

    Department of Bioinformatics and Computational Biology, Cell Signaling Technology Inc., Danvers, MA, USA

    4 shared publications
  • Vaughan Latham

    Department of Bioinformatics and Computational Biology, Cell Signaling Technology Inc., Danvers, MA, USA

    4 shared publications
  • Jon M. Kornhauser

    Cell Signaling Technology, 3 Trask Lane, Danvers, MA 01923, USA

    3 shared publications
  • Junichi Ohara

    Laboratory of Immunology National Institute of Allergy and Infectious Diseases National Institutes of Health Bethesda, Maryland 20892

    3 shared publications
  • Junichiro Mizuguchi

    Laboratory of Immunology National Institute of Allergy and Infectious Diseases National Institutes of Health Bethesda, Maryland 20892

    3 shared publications

Latest Publications

  • Open Access

    Host protein kinases required for SARS-CoV-2 nucleocapsid phosphorylation and viral replication

    by Tomer M. Yaron, Brook E. Heaton, Tyler M. Levy, Jared L. Johnson, Tristan X. Jordan, Benjamin M. Cohen, Alexander Kerelsky, Ting-Yu Lin, Katarina M. Liberatore, Danielle K. Bulaon, et al.

    Multiple coronaviruses have emerged independently in the past 20 years that cause lethal human diseases. Although vaccine development targeting these viruses has been accelerated substantially, there remain patients requiring treatment who cannot be vaccinated or who experience breakthrough infections. Understanding the common host factors necessary for the life cycles of coronaviruses may reveal conserved therapeutic targets. Here, we used the known substrate specificities of mammalian protein kinases to deconvolute the sequence of phosphorylation events mediated by three host protein kinase families (SRPK, GSK-3, and CK1) that coordinately phosphorylate a cluster of serine and threonine residues in the viral N protein, which is required for viral replication. We also showed that loss or inhibition of SRPK1/2, which we propose initiates the N protein phosphorylation cascade, compromised the viral replication cycle. Because these phosphorylation sites are highly conserved across coronaviruses, inhibitors of these protein kinases not only may have therapeutic potential against COVID-19 but also may be broadly useful against coronavirus-mediated diseases.


  • Open Access

    Systematic analysis of the intersection of disease mutations with protein modifications

    by Claire M. Simpson, Bin Zhang, Peter V. Hornbeck, Florian Gnad

    Perturbed posttranslational modification (PTM) landscapes commonly cause pathological phenotypes. The Cancer Genome Atlas (TCGA) project profiles thousands of tumors allowing the identification of spontaneous cancer-driving mutations, while Uniprot and dbSNP manage genetic disease-associated variants in the human population. PhosphoSitePlus (PSP) is the most comprehensive resource for studying experimentally observed PTM sites and the only repository with daily updates on functional annotations for many of these sites. To elucidate altered PTM landscapes on a large scale, we integrated disease-associated mutations from TCGA, Uniprot, and dbSNP with PTM sites from PhosphoSitePlus. We characterized each dataset individually, compared somatic with germline mutations, and analyzed PTM sites intersecting directly with disease variants. To assess the impact of mutations in the flanking regions of phosphosites, we developed DeltaScansite, a pipeline that compares Scansite predictions on wild type versus mutated sequences. Disease mutations are also visualized in PhosphoSitePlus. Characterization of somatic variants revealed oncoprotein-like mutation profiles of U2AF1, PGM5, and several other proteins, showing alteration patterns similar to germline mutations. The union of all datasets uncovered previously unknown losses and gains of PTM events in diseases unevenly distributed across different PTM types. Focusing on phosphorylation, our DeltaScansite workflow predicted perturbed signaling networks consistent with calculations by the machine learning method MIMP. We discovered oncoprotein-like profiles in TCGA and mutations that presumably modify protein function by impacting PTM sites directly or by rewiring upstream regulation. The resulting datasets are enriched with functional annotations from PhosphoSitePlus and present a unique resource for potential biomarkers or disease drivers.


  • Top Cited Papers
    Open Access

    A Curated Resource for Phosphosite-specific Signature Analysis

    by Karsten Krug, Philipp Mertins, Bin Zhang, Peter Hornbeck, Rajesh Raju, Rushdy Ahmad, Matthew Szucs, Filip Mundt, Dominique Forestier, Judit Jane-Valbuena, et al.


  • Top Cited Papers
    Open Access

    15 years of PhosphoSitePlus®: integrating post-translationally modified sites, disease variants and isoforms

    by Peter V Hornbeck, Jon M Kornhauser, Vaughan Latham, Beth Murray, Vidhisha Nandhikonda, Alex Nord, Elżbieta Skrzypek, Travis Wheeler, Bin Zhang, Florian Gnad

    For 15 years the mission of PhosphoSitePlus® (PSP, https://www.phosphosite.org) has been to provide comprehensive information and tools for the study of mammalian post-translational modifications (PTMs). The number of unique PTMs in PSP is now more than 450 000 from over 22 000 articles and thousands of MS datasets. The most important areas of growth in PSP are in disease and isoform informatics. Germline mutations associated with inherited diseases and somatic cancer mutations have been added to the database and can now be viewed along with PTMs and associated quantitative information on novel ‘lollipop' plots. These plots enable researchers to interactively visualize the overlap between disease variants and PTMs, and to identify mutations that may alter phenotypes by rewiring signaling networks. We are expanding the sequence space to include over 30 000 human and mouse isoforms to enable researchers to explore the important but understudied biology of isoforms. This represents a necessary expansion of sequence space to accommodate the growing precision and depth of coverage enabled by ongoing advances in mass spectrometry. Isoforms are aligned using a new algorithm. Exploring the worlds of PTMs and disease mutations in the entire isoform space will hopefully lead to new biomarkers, therapeutic targets, and insights into isoform biology.


  • Open Access

    Splice-Aware Multiple Sequence Alignment of Protein Isoforms

    by Alex Nord, Peter Hornbeck, Kaitlin Carey, Travis Wheeler

    Multiple sequence alignment (MSA) is a classic problem in computational genomics. In typical use, MSA software is expected to align a collection of homologous genes, such as orthologs from multiple species or duplication-induced paralogs within a species. Recent focus on the importance of alternatively-spliced isoforms in disease and cell biology has highlighted the need to create MSAs that more effectively accommodate isoforms. MSAs are traditionally constructed using scoring criteria that prefer alignments with occasional mismatches over alignments with long gaps. Alternatively spliced protein isoforms effectively contain exon-length insertions or deletions (indels) relative to each other, and demand an alternative approach. Some improvements can be achieved by making indel penalties much smaller, but this is merely a patchwork solution. In this work we present Mirage, a novel MSA software package for the alignment of alternatively spliced protein isoforms. Mirage aligns isoforms to each other by first mapping each protein sequence to its encoding genomic sequence, and then aligning isoforms to one another based on the relative genomic coordinates of their constitutive codons. Mirage is highly effective at mapping proteins back to their encoding exons, and these protein-genome mappings lead to extremely accurate intra-species alignments; splice site information in these alignments is used to improve the accuracy of inter-species alignments of isoforms. Mirage alignments have also revealed the ubiquity of dual-coding exons, in which an exon conditionally encodes multiple open reading frames as overlapping spliced segments of frame-shifted genomic sequence.


  • Integration of protein phosphorylation, acetylation, and methylation data sets to outline lung cancer signaling networks

    by Mark Grimes, Benjamin Hall, Lauren Foltz, Tyler Levy, Klarisa Rikova, Jeremiah Gaiser, William Cook, Ekaterina Smirnova, Travis Wheeler, Neil R. Clark, et al.

    Integrated multiomics network analysis reveals signaling profiles in lung cancer.


  • Open Access

    Crk Tyrosine Phosphorylation Regulates PDGF-BB–inducible Src Activation and Breast Tumorigenicity and Metastasis

    by Sushil Kumar, Bin Lu, Viralkumar Davra, Peter Hornbeck, Kazuya Machida, Raymond B. Birge

    The activity of Src family kinases (Src being the prototypical member) is tightly regulated by differential phosphorylation on Tyr416 (positive) and Tyr527 (negative), a duet that reciprocally regulates kinase activity. The latter negative regulation of Src on Tyr527 is mediated by C-terminal Src kinase (CSK) that phosphorylates Tyr527 and maintains Src in a clamped negative regulated state by promoting an intramolecular association. Here it is demonstrated that the SH2- and SH3-domain containing adaptor protein CrkII, by virtue of its phosphorylation on Tyr239, regulates the Csk/Src signaling axis to control Src activation. Once phosphorylated, the motif (PIpYARVIQ) forms a consensus sequence for the SH2 domain of CSK to form a pTyr239-CSK complex. Functionally, when expressed in Crk−/− MEFs or in Crk+/+ HS683 cells, Crk Y239F delayed PDGF-BB–inducible Src Tyr416 phosphorylation. Moreover, expression of Crk Y239F in HS683 cells delayed Src kinase activation and suppressed the cell-invasive and -transforming phenotypes. Finally, through loss-of-function and epistasis experiments using CRISPR-Cas9–engineered 4T1 murine breast cancer cells, Crk Tyr239 is implicated in breast cancer tumor growth and metastasis in orthotopic immunocompetent 4T1 mice model of breast adenocarcinoma. These findings delineate a novel role for Crk Tyr239 phosphorylation in the regulation of Src kinases, as well as a potential molecular explanation for a long-standing question as to how Crk regulates the activation of Src kinases. Implications: These findings provide new perspectives on the versatility of Crk in cancer by demonstrating how Crk mechanistically drives, through a tyrosine phosphorylation–dependent manner, tumor growth, and metastasis. Mol Cancer Res; 16(1); 173–83. ©2017 AACR.


  • Top Cited Papers
    Open Access

    Clustergrammer, a web-based heatmap visualization and analysis tool for high-dimensional biological data

    by Nicolas F. Fernandez, Gregory W. Gundersen, Adeeb Rahman, Mark L. Grimes, Klarisa Rikova, Peter Hornbeck, Avi Ma’ayan

    Most tools developed to visualize hierarchically clustered heatmaps generate static images. Clustergrammer is a web-based visualization tool with interactive features such as: zooming, panning, filtering, reordering, sharing, performing enrichment analysis, and providing dynamic gene annotations. Clustergrammer can be used to generate shareable interactive visualizations by uploading a data table to a web-site, or by embedding Clustergrammer in Jupyter Notebooks. The Clustergrammer core libraries can also be used as a toolkit by developers to generate visualizations within their own applications. Clustergrammer is demonstrated using gene expression data from the cancer cell line encyclopedia (CCLE), original post-translational modification data collected from lung cancer cells lines by a mass spectrometry approach, and original cytometry by time of flight (CyTOF) single-cell proteomics data from blood. Clustergrammer enables producing interactive web based visualizations for the analysis of diverse biological data.


  • Open Access

    Reciprocal regulation of Abl kinase by Crk Y251 and Abi1 controls invasive phenotypes in glioblastoma

    by Sushil Kumar, Bin Lu, Updesh Dixit, Sajjad Hossain, Yongzhang Liu, Jing Li, Peter Hornbeck, Weiming Zheng, Adam G. Sowalsky, Leszek Kotula, et al.

    Reciprocal regulation of Abl kinase by Crk Y251 and Abi1 controls invasive phenotypes in glioblastoma


  • Top Cited Papers
    Open Access

    PhosphoSitePlus, 2014: mutations, PTMs and recalibrations

    by Peter V. Hornbeck, Bin Zhang, Beth Murray, Jon M. Kornhauser, Vaughan Latham, Elzbieta Skrzypek

    PhosphoSitePlus® (PSP, http://www.phosphosite.org/), a knowledgebase dedicated to mammalian post-translational modifications (PTMs), contains over 330 000 non-redundant PTMs, including phospho, acetyl, ubiquityl and methyl groups. Over 95% of the sites are from mass spectrometry (MS) experiments. In order to improve data reliability, early MS data have been reanalyzed, applying a common standard of analysis across over 1 000 000 spectra. Site assignments with P > 0.05 were filtered out. Two new downloads are available from PSP. The ‘Regulatory sites’ dataset includes curated information about modification sites that regulate downstream cellular processes, molecular functions and protein-protein interactions. The ‘PTMVar’ dataset, an intersect of missense mutations and PTMs from PSP, identifies over 25 000 PTMVars (PTMs Impacted by Variants) that can rewire signaling pathways. The PTMVar data include missense mutations from UniPROTKB, TCGA and other sources that cause over 2000 diseases or syndromes (MIM) and polymorphisms, or are associated with hundreds of cancers. PTMVars include 18 548 phosphorlyation sites, 3412 ubiquitylation sites, 2316 acetylation sites, 685 methylation sites and 245 succinylation sites.